# Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

> **NCT05155072** · PHASE1 · COMPLETED · sponsor: **Daewon Pharmaceutical Co., Ltd.** · enrollment: 31 (actual)

## Conditions studied

- Gastritis

## Interventions

- **DRUG:** DW1903
- **DRUG:** DW1903-R1
- **DRUG:** DW1903-R2

## Key facts

- **NCT ID:** NCT05155072
- **Lead sponsor:** Daewon Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-15
- **Primary completion:** 2020-09-07
- **Final completion:** 2020-09-07
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2021-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05155072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05155072, "Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05155072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*